Predictive and Diagnostic Values of Systemic Inflammatory Indices in Bronchopulmonary Dysplasia

Background: Bronchopulmonary dysplasia (BPD) is the most common respiratory complication in preterm infants, and there is a lag in the diagnosis of BPD. Inflammation is a vital pathogenic factor for BPD; we aim to evaluate the predictive and diagnostic values of systemic inflammatory indices in BPD. Methods: Between 1 January 2019 and 31 May 2023, the clinical data of 122 premature infants with a gestational age of <32 weeks in the Department of Neonatology, the Affiliated Huai’an No. 1 People’s Hospital of Nanjing Medical University, were retrospectively collected and classified into non-BPD (n = 72) and BPD (n = 50) groups based on the National Institute of Child Health and Human Development 2018 criteria. To compare the general characteristics of each group, we identified the independent risk variables for BPD using multivariate logistic regression analysis, compared the systemic inflammatory indices at birth, 72 h, 1 week, 2 weeks, and 36 weeks postmenstrual age (PMA), and constructed the receiver operating characteristic curves of neutrophil-to-lymphocyte ratio (NLR) diagnosis of BPD at different time points. Results: ① The independent risk factors for BPD in preterm infants were birth weight, small for gestational age, and days of oxygen therapy (all p < 0.05). ② At 72 h and 1 week after birth, the serum NLR of the BPD group was higher than for the non-BPD group (p < 0.05). Furthermore, the neutrophil count (N), NLR, monocyte-to-lymphocyte ratio (MLR), systemic immune-inflammation index, systemic inflammation response index (SIRI), and pan-immune-inflammation value of infants with BPD were higher than the non-BPD group at 3 weeks after birth (p < 0.05). Moreover, at 36 weeks of PMA, the serum N, NLR, MLR, and SIRI of BPD infants were higher than those of non-BPD infants (p < 0.05). ③ The NLR of infants with and without BPD gradually increased after birth, reaching a peak at 72 h and 1 week, respectively. At 3 weeks postnatal, the NLR had the highest predictive power for BPD, with an area under the curve (AUC) of 0.717 (p < 0.001); the sensitivity was 56% and specificity was 86.1%. In addition, the NLR at 36 weeks of PMA exhibited some diagnostic value for BPD. The AUC was 0.693 (p < 0.001), the sensitivity was 54%, and specificity was 83.3%. Conclusions: At 3 weeks after birth and 36 weeks of PMA, some systemic inflammation indices (like N, NLR, SIRI) of preterm infants with BPD have specific predictive and diagnostic values; these indices may help the management of high-risk preterm infants with BPD.

[1]  Renjithkumar Kalikkot Thekkeveedu,et al.  Bronchopulmonary Dysplasia: Pathogenesis and Pathophysiology , 2023, Journal of clinical medicine.

[2]  X. Ou,et al.  Prognostic Value of Neutrophil to Lymphocyte Ratio for Predicting 90-Day Poor Outcomes in Hospitalized Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease , 2023, International journal of chronic obstructive pulmonary disease.

[3]  Rui Wang,et al.  The clinical value of neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR) and systemic inflammation response index (SIRI) for predicting the occurrence and severity of pneumonia in patients with intracerebral hemorrhage , 2023, Frontiers in Immunology.

[4]  Luca Bonadies,et al.  Prematurity and BPD: what general pediatricians should know , 2023, European Journal of Pediatrics.

[5]  C. Tayman,et al.  Role of Systemic Inflammatory Indices in the Prediction of Moderate to Severe Bronchopulmonary Dysplasia in Preterm Infants. , 2023, Archivos de bronconeumologia.

[6]  Matthew N. Alder,et al.  Olfactomedin-4-Positive Neutrophils in Neonates: Link to Systemic Inflammation and Bronchopulmonary Dysplasia , 2022, Neonatology.

[7]  A. Mangoni,et al.  Clinical significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute exacerbations of COPD: present and future , 2022, European Respiratory Review.

[8]  Yiran Chen,et al.  Prognostic Role of NLR, PLR and MHR in Patients With Idiopathic Pulmonary Fibrosis , 2022, Frontiers in Immunology.

[9]  I. Sas,et al.  The Predictive Role of NLR, d-NLR, MLR, and SIRI in COVID-19 Mortality , 2022, Diagnostics.

[10]  Tao Jiang,et al.  Predictive Value of Systemic Immune-Inflammation index and Neutrophil-to-Lymphocyte Ratio in Patients with Severe COVID-19 , 2022, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[11]  S. Perrone,et al.  Oxidative Stress and Respiratory Diseases in Preterm Newborns , 2021, International journal of molecular sciences.

[12]  N. Rezaei,et al.  Novel Systemic Inflammation Markers to Predict COVID-19 Prognosis , 2021, Frontiers in Immunology.

[13]  V. Bhandari,et al.  Diagnosis and management of bronchopulmonary dysplasia , 2021, BMJ.

[14]  E. Avci,et al.  Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19 , 2020, The American Journal of Emergency Medicine.

[15]  A. Mangoni,et al.  The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients , 2020, Molecules.

[16]  Derick R. Peterson,et al.  Lymphocyte-Specific Biomarkers Associated With Preterm Birth and Bronchopulmonary Dysplasia , 2020, bioRxiv.

[17]  Xingchao Li,et al.  Decreased neutrophil levels in bronchopulmonary dysplasia infants. , 2020, Pediatrics and neonatology.

[18]  W. Göpel,et al.  Preterm birth and sustained inflammation: consequences for the neonate , 2020, Seminars in Immunopathology.

[19]  E. Vasile,et al.  Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study , 2020, Advances in Therapy.

[20]  M. H. Kamel,et al.  Prognostic value of platelet and neutrophil to lymphocyte ratio in COPD patients , 2020, Expert review of respiratory medicine.

[21]  Cuie Chen,et al.  High Neutrophil-to-Lymphocyte Ratio Is an Early Predictor of Bronchopulmonary Dysplasia , 2019, Front. Pediatr..

[22]  H. Takada,et al.  Inflammation in the neonatal period and intrauterine growth restriction aggravate bronchopulmonary dysplasia. , 2019, Pediatrics and neonatology.

[23]  F. Spyropoulos,et al.  Bronchopulmonary Dysplasia: An Update of Current Pharmacologic Therapies and New Approaches , 2018, Clinical medicine insights. Pediatrics.

[24]  T. Raju,et al.  Bronchopulmonary Dysplasia: Executive Summary of a Workshop , 2018, The Journal of pediatrics.

[25]  M. Walsh,et al.  Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012. , 2015, JAMA.

[26]  R. Záhorec Neutrophil-to-lymphocyte ratio, past, present and future perspectives. , 2021, Bratislavske lekarske listy.